Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Fass

Showing results (41-50 of 134) with videos related to

Pageof 14
Sort By:
The American Journal of the Medical Sciences|November 1, 1982
Treatment of osteomyelitis and septic arthritis with cefamandoleB M Bernstein, R J Fass
The Journal of Antimicrobial Chemotherapy|January 1, 1982
Mezlocillin: treatment of skin and soft tissue infectionsR J Fass, R K Kusumi
Antimicrobial Agents and Chemotherapy|September 1, 1986
In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporinsR J Fass, V L Helsel
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|December 1, 1988
In vitro activity of cefixime, a new oral cephalosporinR J Fass, V L Helsel
Annals of the New York Academy of Sciences|July 31, 1974
Light, scanning, and transmission electron microscopy of stable staphylococcal L-formsR J Fass, R B Prior
Diagnostic Microbiology and Infectious Disease|April 1, 1987
In vitro activity of RO 23-6240 (AM-833): a new fluoroquinoloneR J Fass, V L Helsel
Antimicrobial Agents and Chemotherapy|November 1, 1986
In vitro activity of LY146032 against staphylococci, streptococci, and enterococciR J Fass, V L Helsel
Antimicrobial Agents and Chemotherapy|December 1, 1996
Antibiotic-impregnated cement and beads for orthopedic infectionsD A Wininger, R J Fass
Antimicrobial Agents and Chemotherapy|July 1, 1988
In vitro activity of U-76,252 (CS-807), a new oral cephalosporinR J Fass, V L Helsel
American Journal of Clinical Pathology|March 1, 1982
Proposed mezlocillin disk control values for staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Pseudomonas aeruginosa ATCC 27853R B Prior, R J Fass
Pageof 14

Showing results (41-50 of 134) with videos related to

Sort By:
Pageof 14
The American Journal of the Medical Sciences|November 1, 1982
Treatment of osteomyelitis and septic arthritis with cefamandoleB M Bernstein, R J Fass
The Journal of Antimicrobial Chemotherapy|January 1, 1982
Mezlocillin: treatment of skin and soft tissue infectionsR J Fass, R K Kusumi
Antimicrobial Agents and Chemotherapy|September 1, 1986
In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporinsR J Fass, V L Helsel
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|December 1, 1988
In vitro activity of cefixime, a new oral cephalosporinR J Fass, V L Helsel
Annals of the New York Academy of Sciences|July 31, 1974
Light, scanning, and transmission electron microscopy of stable staphylococcal L-formsR J Fass, R B Prior
Diagnostic Microbiology and Infectious Disease|April 1, 1987
In vitro activity of RO 23-6240 (AM-833): a new fluoroquinoloneR J Fass, V L Helsel
Antimicrobial Agents and Chemotherapy|November 1, 1986
In vitro activity of LY146032 against staphylococci, streptococci, and enterococciR J Fass, V L Helsel
Antimicrobial Agents and Chemotherapy|December 1, 1996
Antibiotic-impregnated cement and beads for orthopedic infectionsD A Wininger, R J Fass
Antimicrobial Agents and Chemotherapy|July 1, 1988
In vitro activity of U-76,252 (CS-807), a new oral cephalosporinR J Fass, V L Helsel
American Journal of Clinical Pathology|March 1, 1982
Proposed mezlocillin disk control values for staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Pseudomonas aeruginosa ATCC 27853R B Prior, R J Fass
Pageof 14